The severity of OSA is associated with increased levels of all measured markers of atherosclerotic plaque vulnerability (CD40, CD40L, MCP-1, MMP-9), with significant differences for MCP-1 (p = 0.014) and near-significant difference for CD40 (p = 0.056). This evidence concerns the gene MMP9 and obstructive sleep apnea syndrome.